- Study guides, Class notes & Summaries

US RAC: Chapter 14 Questions and Answers|Latest Update initial grant of pediatric exclusivity - provides additional market exclusivity not just for the pediatric indications or formulations, but for all protected indications and formulations of that sponsor's drug second grant of pediatric exclusivity - attaches only to any period of three-year new clinical investigation exclusivity granted by FDA with respect to a pediatric use supplement containing studies submitted in response ...

-

13 pages

Written in 2024/2025

Grade A+

StudyLoom01

RAC 40 quiz 6 review Questions and Answers Graded A+ For fastening two pieces of rough lumber together the nail used would be A. finishing nail B. Masonry nail C. roofing nail D. common nail D. common nail In the tapping screw dimension "6-20 X 1/2 type AB, slotted hex," the term 20 indicates the A. Head diameter B. Thread diameter C. number of threads D. Length C. number of threads

-

11 pages

Written in 2024/2025

Grade A+

StudyLoom01

US RAC Review Questions RAPS Modules with Complete Solutions 17) From a pre-clinical viewpoint, which of the following constitute pre-clinical activities in medical device development? A) Animal use testing to validate the design of your device B) Bench testing to verify that your design performs as designed C) Biocompatibility/Toxicity testing D) Functional/Safety/Performance testing E) All of the above E) All of the above

-

41 pages

Written in 2024/2025

Grade A+

StudyLoom01

RAC, Regulatory Affairs, RAC 14 Questions and Answers 100% Solved What type of communication will FDA send an applicant when the review division concludes an NDA or ANDA cannot be approved in its present form and certain additional information or clarifications are needed? Complete response letter A company has a new oral drug, GOODDRUG, it wishes to market in the US. Studies on intravenous GOODDRUG have been conducted by several academic centers demonstrating safety and efficacy and...

-

59 pages

Written in 2024/2025

Grade A+

StudyLoom01

RAC 2016 US RAC Practice Exam Questions and Answers|Latest Update Because of reported dispensing errors due to the similarity of proprietary drug names, one of the companies involved has decided to quickly and voluntarily notify physicians and others responsible for providing patient care about the issue via a "Dispensing Error Alert". In this approach, the company is NOT required to: A. Use first class mail and number 10 white envelopes. B. Use appropriate language on the outsi...

-

66 pages

Written in 2024/2025

Grade A+

StudyLoom01

RAC Test 2 Questions and Answers Verified by Experts Special Protocol Assesement Cannot be a dose ranging study. CBER Reviews applications for combination products that are both biologics and devices (interagency agreement) 14 calendar days if product is approved based on draft labeling, the company has this long after approval to submit final labeling

-

4 pages

Written in 2024/2025

Grade A+

StudyLoom01

RAC Test 2 Questions with Complete Solutions Jade Emperor The supreme god in Traditional Chinese Religion Legalism The political philosophy of strict law and order adopted by the Qin Emperors Mohism An alternative to Confucianism that focused on "love" and condemned autocratic political leadership

-

10 pages

Written in 2024/2025

Grade A+

StudyLoom01

US RAC Exam Prep Questions and Answers 100% Solved Commercial Distribution Any distribution of a device intended for human use, which is offered for sale but does not include: internal or interplant transfer within the same parent, subsidiary or affiliate company any device with an approved exemption for investigational use. Common Rule Requires the research institution's IRB to ensure that each research protocol contains adequate provisions to protect a subject during the course of...

-

34 pages

Written in 2024/2025

Grade A+

StudyLoom01

RAPS RAC (Drug) Practice Test Questions and Answers 100% Correct What could form part of the procedures for a non-interventional imposed PASS (Post Authorization Safety Study)? All of the above. Which of the following statements regarding the duties of the Qualified Person (QP) responsible for batch release is correct? The QP is responsible for confirming the quality of medicinal products in accordance with the requirements of the Marketing Authorisation.

-

23 pages

Written in 2024/2025

Grade A+

StudyLoom01

RAC-Drugs Only All Practice Exam Final Questions Graded A+ Which of the following subsystems is NOT required by FDA in order to implement and maintain a Quality System? A. Production and process controls B. Test and control article characterization C. Packaging and labeling controls D. Facility and equipment controls B. Test and control article characterization This is required by 21 CFR 58.105, Good Laboratory Practice for Nonclinical Laboratory Studies, not by quality system or GMP ...

-

442 pages

Written in 2024/2025

Grade A+

StudyLoom01